Casdin Capital, LLC Standard Biotools Inc. Transaction History
Casdin Capital, LLC
- $855 Million
- Q1 2025
A detailed history of Casdin Capital, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 76,075,636 shares of LAB stock, worth $82.2 Million. This represents 9.61% of its overall portfolio holdings.
Number of Shares
76,075,636
Previous 71,254,677
6.77%
Holding current value
$82.2 Million
Previous $125 Million
34.11%
% of portfolio
9.61%
Previous 10.73%
Shares
5 transactions
Others Institutions Holding LAB
# of Institutions
151Shares Held
280MCall Options Held
6KPut Options Held
36.6K-
Viking Global Investors LP58.7MShares$63.3 Million0.21% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$23.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$18.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$11.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.21MShares$7.78 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $84.9M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...